XML 67 R35.htm IDEA: XBRL DOCUMENT v3.19.3
Discontinued Operations (Tables)
9 Months Ended
Sep. 30, 2019
Netsmart [Member]  
Summary of Discontinued Operations in Financial Statements

The following table summarizes Netsmart’s major income and expense line items as reported in the consolidated statements of operations for the three and nine months ended September 30, 2018:

 

 

Three Months Ended

 

 

Nine Months Ended

 

(In thousands)

 

September 30, 2018

 

 

September 30, 2018

 

Major income and expense line items related to Netsmart:

 

 

 

 

 

 

 

 

Revenue:

 

 

 

 

 

 

 

 

Software delivery, support and maintenance

 

$

56,259

 

 

$

157,393

 

Client services

 

 

33,590

 

 

 

96,773

 

Total revenue

 

 

89,849

 

 

 

254,166

 

Cost of revenue:

 

 

 

 

 

 

 

 

Software delivery, support and maintenance

 

 

16,441

 

 

 

45,110

 

Client services

 

 

23,905

 

 

 

68,440

 

Amortization of software development and acquisition related assets

 

 

9,084

 

 

 

24,991

 

Total cost of revenue

 

 

49,430

 

 

 

138,541

 

Gross profit

 

 

40,419

 

 

 

115,625

 

Selling, general and administrative expenses

 

 

25,089

 

 

 

74,390

 

Research and development

 

 

6,715

 

 

 

17,753

 

Amortization of intangible and acquisition-related assets

 

 

6,391

 

 

 

17,580

 

Income from discontinued operations of Netsmart

 

 

2,224

 

 

 

5,902

 

Interest expense

 

 

(16,092

)

 

 

(43,918

)

Other gain (loss)

 

 

11

 

 

 

(6

)

Loss from discontinued operations of Netsmart before

    income taxes

 

 

(13,857

)

 

 

(38,022

)

Income tax benefit

 

 

2,152

 

 

 

8,938

 

Loss from discontinued operations, net of tax for Netsmart

 

$

(11,705

)

 

$

(29,084

)

Horizon Clinicals and Series2000 [Member]  
Summary of Discontinued Operations in Financial Statements

The following table summarizes the major classes of line items constituting income (loss) of the discontinued operations with the sunset businesses of Horizon Clinicals and Series2000 Revenue Cycle, as reported in the consolidated statements of operations for the three and nine months ended September 30, 2018:

 

 

Three Months Ended

 

 

Nine Months Ended

 

(In thousands)

 

September 30, 2018

 

 

September 30, 2018

 

Major classes of line items constituting pretax profit (loss) of

   discontinued operations for Horizon Clinicals and

   Series2000 Revenue Cycle:

 

 

 

 

 

 

 

 

Revenue:

 

 

 

 

 

 

 

 

Software delivery, support and maintenance

 

$

0

 

 

$

9,441

 

Client services

 

 

0

 

 

 

404

 

Total revenue

 

 

0

 

 

 

9,845

 

Cost of revenue:

 

 

 

 

 

 

 

 

Software delivery, support and maintenance

 

 

0

 

 

 

2,322

 

Client services

 

 

0

 

 

 

830

 

Total cost of revenue

 

 

0

 

 

 

3,152

 

Gross profit

 

 

0

 

 

 

6,693

 

Research and development

 

 

0

 

 

 

1,651

 

(Loss) income from discontinued operations for Horizon Clinicals

   and Series2000 Revenue Cycle before income taxes

 

 

0

 

 

 

5,042

 

Income tax benefit (provision)

 

 

0

 

 

 

(1,311

)

(Loss) income from discontinued operations, net of tax for Horizon

   Clinicals and Series2000 Revenue Cycle

 

$

0

 

 

$

3,731